The CTN is committed to maximizing the impact of research and ultimately improving the health of Canadians by applying knowledge gained through research at home and abroad into applications and practice.

CIHR defines knowledge translation (KT) as a “dynamic and iterative process that includes synthesis, dissemination, exchange and ethically-sound application of knowledge to improve the health of Canadians, provide more effective health services and products, and strengthen the health care system.”

Studies supported by the CTN follow the CIHR KT model and employ two types of knowledge translation in their study designs: integrated KT (iKT) and end-of-grant KT.

CIHR Knowledge to Action Cycle

End-of-grant KT

The end-of-grant KT approach is primarily focused on disseminating findings to knowledge users. The CTN supports these activities through a number of channels including: peer reviewed publications, presentations, posters, plain language results in the CTN newsletter, annual reviews, websites, community blogs, workshops and through social media.

iKT approach

The integrated, iKT approach emphasizes the role of an engaged knowledge user throughout the research process. Having engaged knowledge users can improve KT activities and helps to ensure that research findings are directly relevant to and used by knowledge users. The iKT approach often includes an end-of-grant KT dissemination plan as well.

CTN Knowledge Translation Resources

STBBIs and the CTN

HIV, Aging, and the CTN

Cure Research and the CTN

Treatment Guidelines

CTN Research Publications

Latest News

The enigma of HIV’s effects on aging

| Uncategorized | No Comments

The average age of people living with HIV in Canada is rising. CTN and BC-CfE researchers are working to understand the factors associated with aging in HIV. This story was originally published by BC-CfE.

Guest Blog: Dr. Haneesha Mohan

| Uncategorized | No Comments

Dr. Haneesha Mohan, CTN Postdoctoral Research Fellow at the University Health Network, describes her work on understanding the metabolic diseases and birth defects potentially caused by ARV medications.

Let’s Talk About Stigma: HIV in 2020

| Uncategorized | No Comments

We talked to three community members to get their unique perspectives on the pervasive impact of HIV-related stigma and what we can do to combat it

Could Cannabis Help Prevent HIV-Related Illnesses?

| Uncategorized | No Comments

CTN Investigators Drs. Cecilia Costiniuk and Ali Jenabian publish a thorough editorial review of cannabis research in HIV and inflammation